We are thrilled to invite you to the biggest pharmaceutical event of the year – CPHI 2023 in Barcelona! 🌍

QUINTA-ANALYTICA as a part of Conscio Group, along with our network of companies:, Gen-Plus GmbH & Co. KG, EL Labs, LVA GmbH and strategic partner DiHeSys – Digital Health Systems GmbH, are looking forward to meeting our current partners and friends, and to establish new collaborations and opportunities.

Come meet with us and explore how our collective expertise can drive innovation in #pharmaceuticalresearch #PharmaInnovation, #Bioanalysis, #ClinicalTrials and #manufacturingprocces.

📅 Date: 24th-26th October
📍 Booth: 4H30

🤝 If you’re interested in meeting with us, mention us in the comments, send us a private message or contact us at info@consciogroup.com or sales@quinta.cz, and we’ll schedule a meeting.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

ALL POSTS